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Abstract
Retinoids are mostly stored as retinyl esters in hepatic stellate cells (HSCs) through esterification of retinol and fatty acid,
catalyzed by lecithin-retinol acyltransferase (LRAT). This study is designated to address how retinyl esters are mobilized in
liver injury for tissue repair and wound healing. Initially, we speculated that acute inflammatory cytokines may act as injury
signal to mobilize retinyl esters by down-regulation of LRAT in HSCs. By examining a panel of cytokines we found
interleukin-1 (IL-1) can potently down-regulate mRNA and protein levels of LRAT, resulting in mobilization of retinyl esters in
primary rat HSCs. To simulate the microenvironment in the space of Disse, HSCs were embedded in three-dimensional
extracellular matrix, by which HSCs retaine quiescent phenotypes, indicated by up-regulation of LRAT and accumulation of
lipid droplets. Upon IL-1 stimulation, LRAT expression went down together with mobilization of lipid droplets. Secreted
factors from Kupffer cells were able to suppress LRAT expression in HSCs, which was neutralized by IL-1 receptor antagonist.
To explore the underlying mechanism we noted that the stability of LRAT protein is not significantly regulated by IL-1,
indicating the regulation is likely at transcriptional level. Indeed, we found that IL-1 failed to down-regulate recombinant
LRAT protein expressed in HSCs by adenovirus, while transcription of endogenous LRAT was promptly decreased. Following
liver damage, IL-1 was promptly elevated in a close pace with down-regulation of LRAT transcription, implying their
causative relationship. After administration of IL-1, retinyl ester levels in the liver, as measured by LC/MS/MS, decreased in
association with down-regulation of LRAT. Likewise, IL-1 receptor knockout mice were protected from injury-induced down-
regulation of LRAT. In summary, we identified IL-1 as an injury signal to mobilize retinyl ester in HSCs through down-
regulation of LRAT, implying a mechanism governing transition from hepatic injury to wound healing.
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Introduction
Hepatic stellate cells (HSCs) are vitamin A (retinol)-storing
pericytes, residing in the space of Disse between sinusoidal
endothelial cells and hepatocytes [1]. Lipid droplets in quiescent
HSCs consist of 30 to 40% retinyl ester and other components such
as triglyceride, cholesterol, phospholipids, and free fatty acids [2]. In
the liver, hepatocytes absorb retinoids as retinyl ester, which is
comprised of chylomicron remnant and combined with retinol
binding protein (RBP) [3][4]. In the cytoplasm of hepatocytes,
retinyl ester is hydrolyzed to retinol and transferred from RBP to
cellular retinol bindingprotein-I (CRBP-I) [5].Bindingwith CRBP-
I in HSCs, the retinol is esterified with fatty acids by two enzymes,
namely lecithin retinol acyltransferase (LRAT) or acyl-coenzyme-A
retinol acyltransferase (ARAT) using two different coenzyme factors
[6]. The important role of LRAT in retinoid storage has been
demonstrated by the gene knockout mice, showing striking absence
of retinyl ester containing lipid droplets in HSCs [7]. Among the
retinoid components, retinoic acid is the most active biological
compound and is essential for embryonic development of all
chordate animals. Once mobilized from retinyl ester,the free retinol
can be sequentially oxidized to retinoic acid by retinol dehydroge-
nases (i.e. Rdh10) that oxidize retinol to retinaldehyde, and
retinaldehyde dehydrogenases (Raldh1, Raldh2, and Raldh3) that
metabolize retinaldehyde to retinoic acid [8]. The elevated retinoic
acid may help wound closure by immune regulation/suppression,
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+ cells as
observed by one of the authors [9]. Moreover, retinoic acid can
suppress pro-inflammatory cytokine-induced matrix metalloprotei-
nases (MMPs) by down-regulating JNK-AP-1 signaling [10].
Administration of all-trans retinoic acid alleviated the liver injury
and reduced an incidence of death following hepatic failure [11].
Upon liver injury, HSCs are promptly mobilized for wound
healing regardless of any disease courses [12]. An early study showed
PDGF in the conditioned medium from Kupffer cells contributed in
part to mobilization of HSC stored retinoid. However, it is largely
unknown as to whether and how injury signal mobilizes retinoid
storage in HSCs during liver damage. Our previous study has
revealed that interleukin-1 (IL-1) plays important roles in orches-
trating liver injury and wound healing through production of MMPs
byHSCs[13].Recently,weshowedIL-1coordinatestheprogression
from hepatic injuryto wound healing and earlyfibrosis through HSC
activation [14]. Thus, we reasoned that the same injury signal, IL-1,
might also mobilize stored retinyl ester in HSCs in acute phase of
liver injury. Released retinol and its derived products from HSCs
may contribute to wound healing and tissue repair.
Results
IL-1 down regulates LRAT in rat HSCs
We reasoned that mobilization of retinyl ester storage for wound
healing is mediated by injury signal from acute phase cytokines or
growth factors. To test our hypothesis,primary rat HSCswere isolated
from Wistar rats. Within a few days after isolation, HSCs retain
retinoid droplets and maintain quiescent phenotypes as indicated by
small nuclei and stellar shape with strong auto-fluorescence under
ultraviolet (UV) excitation. Primacy HSCs were exposed to a panel of
factors including IL-1a, IL-6, tumor necrosis factor (TNF)-a,
transforming growth factor (TGF)-b1, and platelet derived growth
factor (PDGF) for 24 hours. LRAT protein, as measured by Western
blot analysis with a monoclonal antibody against the middle region of
LRAT [15], was constitutively expressed in primary rat HSCs, in line
with the presence of retinyl ester droplets viewed under UV excitation
(Fig. 1A and Fig. 2B). Among tested factors, IL-1a and TNF-a were
identified as the two most potent suppressors for LRAT protein
expression. Then, we determined the efficacy of IL-1a and TNF-a on
LRAT suppression. As shown, IL-1a at 0.1 ng/ml almost completely
inhibited LRAT expression, while TNF-a required ten times higher
concentration at 1 ng/ml to attain the same suppression (Fig. 1B). In
additional study we measured the IC50 for the IL-1a-mediated
suppression of LRAT at 0.05 ng/ml. TGF-b1, at high concentration,
could partially down-regulate LRAT. PDGF and IL-6, on the other
hand, were almost without any effect on LRAT down-regulation
( F i g .1 B ) .I ns u m m a r y ,w ei d e n t i f i e dI L - 1 a as a potent suppressor to
down-regulate LRAT expression in rat HSCs, implying a hierarchy
role of IL-1 in mobilization of retinyl ester in liver injury for tissue
repair and wound healing.
Figure 1. Interleukin-1 potently suppresses LRAT protein in primary rat hepatic stellate cells. Hepatic stellate cells (HSCs) were isolated
from rat liver. The cells were recovered for 2 days in DMEM with 10% FBS, during which the cells maintain quiescent features as indicated by lipid
droplets and stellar shape. The day-2 cells were seeded in 24-well plate (4610
5/well) for another day, followed by treatment with cytokines or growth
factors for additional 24 hours. The protein levels of LRAT in HSCs were analyzed by Western blot. (A) The effects of various cytokines and growth
factors on LRAT protein expression were measured in comparison with GAPDH. (B) The dose effects of IL-1a and TNF –a on LRAT protein expression
were compared (upper panel). The dose effects of PDGF, TGF –b and IL-6 on LRAT protein expression were compared (lower panel). GAPDH was used
as loading control.
doi:10.1371/journal.pone.0026644.g001
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Next, we measured the effects of IL-1 on retinol storage in
HSCs. Without cytokine exposure, isolated HSCs in the early days
exhibited ample of lipid droplets as indicated by phase contrast
microscopy (Fig. 2A). Under UV excitation, retinoids emit auto-
fluorescence which is mostly enriched in peri-nuclear region. After
exposure to IL-1a for 24 hours, big lipid droplets apparently
started to dispense, and on day 3 most of big droplets were
disappeared or mobilized (Fig. 2B). Consequently, fine smeared
auto-fluorescent particles are aligned along cytoplasmic extensions
by HSCs under IL-1 treatment (arrows in Fig. 2B). To accurately
assess total storage of retinoids, we applied LC/MS/MS approach
and quantitatively determined the amount of retinyl palmitate, the
dominant form of stored retinoids in HSCs. After exposure to IL-
1a for 3 days, the retinyl palmitate storage was significantly
reduced in HSCs in comparison to the control treatment (Fig. 2C).
Regarding the time course, LRAT was completely suppressed
within 24 hours after IL-1a exposure, which occurs prior to retinyl
ester depletion (Fig. 1A, 2B). In addition, we revealed cytoplasmic
distribution of LRAT in control HSCs by immunofluorescence
staining with a monoclonal antibody (Fig. 2D). LRAT protein and
vitamin A droplets have a similar distributional pattern in HSCs
(Fig. 2B, D). As expected, under IL-1a treatment, cellular
expression of LRAT was markedly decreased, which is in
agreement with decreased retinoid droplets and retinyl ester
storage. The correlation between reduced auto-fluorescence of
vitamin-A droplets and down-regulation of LRAT in HSCs was
evident by pixel densitometry analysis of the images (Fig. 2E).
IL-1 suppresses LRAT expression by HSCs embedded in
three-dimensional extracellular matrix
As the major extracellular matrix (ECM) producing cells in the
liver, HSCs are lodged in ECM within the space of Disse [16]. We
previously demonstrated that embedding of HSCs in three
dimensional (3D) type-I collagen (Col-I) or 3D Matrigel recapit-
ulates the sinusoidal microenvironment [13]. Further, sensing 3D
ECM is critical for HSCs to make decision about whether and
how much MMPs should be expressed in response to IL-1
stimulation in liver injury. Therefore, we examined an effect of
ECM on LRAT expression and vitamin A storage as well as
response of HSCs to IL-1. We prepared three types of culture
conditions for primary rat HSCs as follows: (i) seeding HSCs on
Figure 2. Interleukin-1 induced mobilization of retinyl ester in primary rat hepatic stellate cells is related to down-regulation of
LRAT. Primary rat HSCs were cultured on plastic plate and treated with or without IL-1a (10 ng/ml) for 3 days. (A) Phase contrast images of HSCs. (B)
Vitamin A auto-fluorescence in HSCs under UV excitation. Arrows indicate the small droplets that undergo mobilization along cytoplasmic processes
as visualized by UV excitation. (C) Retinyl palmitate storage was measured by LC/MS/MS analysis, by which all-trans retinoic acid was used as an
internal control for sample normalization. Results are expressed as ng/10
6 cells. *P,0.05 (n=6). (D) Immunofluorescence staining for LRAT (red) in
HSCs. Nuclei are indicated by DAPI staining (blue). Original magnification 6200. (E) Densitometry (pixel) analysis of 5 independent images or fields.
*P,0.05.
doi:10.1371/journal.pone.0026644.g002
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HSCs in 3D Matrigel. After overnight recovery, the cultures were
exposed to IL-1a or not for additional 18 hours. As expected,
mRNA of LRAT is at the lowest level by culture on plastic, and
the highest level by culture in 3D Matrigel (Fig. 3A). Under IL-1a
treatment, levels of LRAT mRNA went down in all of three
culture conditions, showing the dominant role of IL-1 in down-
regulation of LRAT. We then inspected protein levels of LRAT
in HSCs by three culture conditions. When cultured on plastic,
HSCs undergo ‘‘myofibroblastic trans-differentiation’’, while
LRAT protein was steadily increased, which may reflect a
feedback compensation for the loss of retinoid storage. In
24 hours of treatment with IL-1, LRAT protein was totally
vanished in HSCs cultured on plastic (Fig. 3B. To visualize the
remained LRAT protein, we increased loading of IL-1 treated
samples, where IL-1 still dominantly suppressed LRAT protein).
Under IL-1 treatment, LRAT protein was significantly decreased
by HSCs cultured in 3D Col-I or Matrigel, although residual
LRAT protein was still detected after 48 hour treatment with IL-
1a (Fig. 3C, 3D), which is in line with LRAT mRNA
measurement (Fig. 3A). In 3D Matrigel, big lipid droplets
showing auto-fluorescence were evident in HSCs. Under IL-1
stimulation, the droplets were apparently distributed or dispensed
into smear microns in cytoplasmic extensions (Fig. 3E). Given the
fact of prompt suppression of LRAT mRNA in 3D ECM by IL-1
but slow pace of down-regulation of LRAT protein, these results
suggested that 3D ECM may modulate the turnover of LRAT
expression.
Down-regulation of LRAT by IL-1 at mRNA level
Next we measured mRNA levels of LRAT and CRBP-I in
response to IL-1 challenge in primary HSCs. Messenger RNA of
LRAT was steadily elevated in the course of HSC culture, in
agreement with increased protein level of LRAT (Fig. 3B, 4A). In
contrast, mRNA of CRBP-I was constantly expressed. After
6 hours of IL-1 stimulation, mRNA of LRAT was apparently
suppressed. At 24 hour time point, LRAT mRNA level was
significantly decreased in IL-1-treated HSCs compared to the
control, whereas CRBP-I mRNA level was not significantly
affected by IL-1 (Fig. 4B).
Figure 3. Interleukin-1 suppresses LRAT expression in primary rat hepatic stellate cells cultured in 3D ECM. (A) HSCs in equal number
were seeded on plastic or embedded in 3D ECM (type I collagen or Matrigel, 1610
5 cells in 0.4 cm
3). After recovery, the cultures were treated with or
without IL-1 (10 ng/ml) for 18 hours. LRAT gene expression was measured by Affymetrix DNA microarray analysis, which has been extensively
calibrated for many genes by qRT-PCR. (B–D) The levels of LRAT protein expressed by HSCs cultured on plastic or in 3D ECM. The effects of IL-1
treatments on LRAT expression were measured by Western blot analysis. GAPDH was used as loading control. (E) Vitamin A autofluorescence in the
cultures was visualized by UV excitation for HSCs cultured in 3D ECM treated with or without IL-1 for 3 days. Original magnification 6200.
doi:10.1371/journal.pone.0026644.g003
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We compared the kinetics of LRAT mRNA with the kinetics of
LRAT protein after IL-1 challenge. In the course of culture, both
mRNA and protein levels of LRAT in HSCs were steadily
increased in parallel (Fig. 4C). In IL-1 treated HSCs, down-
regulation of LRAT mRNA closely mirrored its protein reduction
(Fig. 4A, C), suggesting that the regulation is more likely at mRNA
level rather than protein degradation. We also measured if IL-1
can enhance the degradation of LRAT protein. HSCs were
treated by cycloheximide (20 mg/ml) together with or without IL-
1a for a time course. In such experiment we did not find that IL-1
can significantly increase the degradation rate (data not shown),
suggesting the key regulation by IL-1 is at transcriptional level. To
further demonstrate the notion we cloned the full length of rat
LRAT cDNA through reverse transcription of RNA extracts from
rat HSCs, the open reading frame was subcloned into the
adenovirus (Ad.LRAT). The size of expressed protein matched
well the predicted size of LRAT protein, and can be recognized by
a monoclonal antibody against a peptide derived from LRAT.
Also in the 293A cells, the ectopically expressed LRAT exhibited
doubled bands akin to endogenous LRAT (Fig. 5A). We then
examined the ectopic LRAT and its regulation in HSCs. In a
control condition, HSCs were transduced by adenoviral vector
expressing GFP (Ad.GFP). Under IL-1a treatment, the endoge-
nous LRAT was promptly decreased in control HSCs transduced
with Ad.GFP (Fig. 5B). In contrast, IL-1a failed to down-regulate
the ectopically expressed LRAT protein, which supports the
notion that IL-1 does not promote degradation of LRAT protein.
Retinoid droplets are composed of both retinyl ester and other
lipids [3]. As revealed by Oil red O staining, the droplets were
ample in the control HSCs, and were deprived under IL-1
exposure (Fig. 5C, right upper panel). HSCs, which ectopically
express LRAT, were resistant to IL-1-induced mobilization of
retinyl ester droplets, indicating LRAT as a key enzyme which is
sufficient to restore retinoid storage (Fig. 5C, right lower panel).
Secreted factor(s) from Kupffer cells suppressing LRAT in
HSCs is identified as IL-1
Kupffer cells (KCs), resident liver macrophages, are the major
source of inflammatory cytokines and injury signals in innate
immunity. We speculated that KCs may transmit injury signals to
activate HSCs for mobilization of retinoid in liver wound healing.
Therefore, we inspected the effects of KCs, particularly their
secreted factors, on the expression of LRAT in HSCs. Conditioned
medium of primary rat KCs (KC-CM) was prepared and applied to
HSCs for additional 18 hours (Fig. 6A). The expression of LRAT in
HSCs was thoroughly suppressed by KC secreted factors presented
intheconditioned medium.ApplicationofIL-1receptorantagonist,
IL-1RA (1 mg/ml) to the conditioned medium fully neutralized the
inhibitory function of KC-CM and restored the lost LRAT
expression (Fig. 6B, lane 4). These results demonstrate IL-1 as a
majorinjurysignalsecretedfromKCstosuppressLRAT expression
in HSCs. In another experiment we activated KCs by LPS (5 mg/
ml) treatment, and the consequent conditioned medium had
enormous inhibitory function to suppress LRAT in HSCs, which
is in line with IL-1 expression (data not shown).
Figure 4. Interleukin-1 down-regulates LRAT mRNA in primary rat hepatic stellate cells. HSCs were cultured on plastic for indicated times
with or without of IL-1 (10 ng/ml). The mRNA levels of LRAT (A) and CRBP-I (B) were measured by qRT-PCR. Results (mean 6 SD) are expressed as
relative folds of increase to 0 hr time point. NS: not significantly different, *P,0.05 (n=3/group/time point) as significance. (C) The time course of
LRAT protein in HSCs was assessed by Western blot. GAPDH: loading control.
doi:10.1371/journal.pone.0026644.g004
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We clearly demonstrated the multiple roles of IL-1 in down-
regulation of LRAT mRNA, LRAT protein, and mobilization of
retinoid storage in primary rat HSCs. Next, we investigated those
events in animal models. Initially, we tested injury induced-
regulation of LRAT. Wild type (WT) mice were given a single
intraperitoneal injection of thioacetamide (TAA) at 0.2 mg/g body
weight. We then measured mRNA levels of IL-1a, IL-1b and
LRAT in liver samples harvested at 12, 24, and 48 hours after
TAA injection. At 12 hour time point, the IL-1a and IL-1b
mRNA levels were promptly increased to 3 and 8 folds
respectively, whereas LRAT mRNA level was not yet decreased
significantly at this time point (Fig. 7A). At 24 hour time point,
LRAT mRNA level significantly dropped by 70% in comparison
to the control. At 48 hours after injury, IL-1 expression returned
to basal level, while LRAT mRNA conversely started restoration.
The timely closed association between elevated IL-1 and down-
regulated LRAT in liver injury indicates a possible causal
relationship. To test this relationship, we performed two additional
experiments. First, we examined hepatic LRAT expression at both
Figure 6. Identification of Kupffer cell secreted factor which suppresses LRAT expression in hepatic stellate cells as interleukin-1.
(A) A diagram of experimental design. (B) Conditioned medium was prepared by culture of primary rat Kupffer cells (KCs) for 3 days. A portion of the
conditioned medium was added to HSC culture for 18 hours. The inhibitory effects of KC secreted factors on LRAT expression by HSCs were analyzed
by Western blot. To demonstrate the contribution of IL-1 in the conditioned medium of KCs, IL-1 receptor antagonist (IL-1RA, at 1 mg/ml) was added
to the KC-CM prior to the treatment for HSCs. GAPDH: loading control.
doi:10.1371/journal.pone.0026644.g006
Figure 5. Interleukin-1 down regulates endogenous LRAT but not the ectopically expressed recombinant LRAT, indicating
regulation is not at protein level. Coding region of rat LRAT gene was cloned and confirmed by DNA sequencing. Recombinant rat LRAT was
expressed by adenoviral vector (Ad.LRAT) in 293A cells, and GFP expressing adenoviral vector (Ad.GFP) was used as the control. The expression of
LRAT protein was assessed by Western blot analysis. GAPDH was used as loading control. (B) HSCs were transduced by adenoviral vectors with MOI at
100. Three days after transduction, HSCs were treated with or without IL-1 (10 ng/ml) for additional 3 days. As shown by Western blot analysis, the
endogenous LART but not recombinant one is down-regulated by IL-1, indicating the regulation is not at protein level. (C) Oil red O staining for each
group of HSCs. As shown, ectopic expression of recombinant LRAT attenuated IL-1-indcued mobilization of lipid droplets in HSCs. Original
magnification 6200.
doi:10.1371/journal.pone.0026644.g005
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2/2 (IL-1R
2/2) mice
and WT mice after liver injury. As expected, LRAT levels went
down in WT mice after TAA injection, while IL-1R
2/2 mice were
partially, but significantly protected from TAA-induced LRAT
down-regulation (Fig. 7B). Second, we explored if injection of IL-1
protein can sufficiently suppress LRAT expression in the liver in a
way bypassing the injury. After 24 hours of intravenous injection
with IL-1a (20 ng), LRAT protein in liver was substantially
decreased (Fig.7 C). As a positive indicator of IL-1a effect on liver
injury, we detected increased MMP-9 level in the liver tissues of
IL-1a injected mice (Fig. 7C). Then, we measured the amount of
retinyl palmitate in liver tissues of the mice subjected to IL-1a
injection. As measured by LC/MS/MS, retinyl palmitate was
significantly reduced in liver tissues from IL-1a injected mice in
comparison to the control ones (Fig. 7D).
Regulation of LRAT in HSCs from injured rat liver
Primary HSCs used in our work were isolated from rats. Rat
HSCs are more sensitive to IL-1 stimulation than HSCs from mice
(Han et al., unpublished). We thus examined the regulation of
LRAT in HSCs isolated from rat liver samples after a single
injection of carbon tetrachloride (CCl4) or mineral oil as control.
LRAT mRNA and its protein expression were substantially down-
regulated in HSCs directly isolated from CCl4-injected rats than
HSCs from the control (Fig. 8A). Similarly, in the whole liver,
LRAT mRNA level was also suppressed by CCl4 injection
(Fig. 8B). We also measured the association between reduction
of LRAT and increase of IL-1 at protein levels. Activation of
HSCs in liver injury was monitored by increased a-smooth muscle
actin (a-SMA) protein. As expected, after a single injection of
CCl4, IL-1b and a-SMA expressions were increased, whereas
LRAT expression was decreased (Fig. 8C and D). Finally, we
performed immunofluorescence staining for LRAT and desmin in
rat livers. Desmin-positive HSCs also expressed LRAT in the liver
of control rat, demonstrating the identity of HSCs by the two
major markers (Fig. 8E). As expected, LRAT expression in
desmin-positive HSCs was reduced by CCl4 induced-liver injury.
Taken together, these results support our notion that IL-1
functions as a common injury signal to down-regulate LRAT
expression in acute liver injury of both mice and rats.
Figure 7. Interleukin-1 mediates down-regulation of LRAT in acute liver injury by mouse model. (A) Acute liver injury in WT mice was
induced by challenge with TAA (0.2 mg/g body weight) via i.p. injection. Saline was used for control. Time course of mRNA levels for LRAT, IL-1a, and
IL-1b in the liver was measured by qRT-PCR. Results (mean 6 SD) are expressed as folds of increase related to the saline injected group (n=5). (B) To
determine the contribution of IL-1 toward injury-induced down-regulation of LRAT, IL-1R
2/2 and WT mice were subjected to TAA injection. After
24 hours, mRNA level of LRAT was measured by qRT-PCR. Results (mean 6 SD) are expressed as folds of increase relative to normal saline-injected WT
mice. *P,0.05, #P,0.01. LRAT protein expression was assessed by Western blot. GAPDH: loading control. (C) WT mice were intravenously injected
with recombinant IL-1a protein (20 ng) or saline for 24 hours. LRAT and MMP-9 levels in the liver tissues were examined by Western blot and
zymography analysis respectively. (D) Hepatic retinyl palmitate levels after IL-1 injection for 24 hours were measured by LC/MS/MS using liver tissues
from mice receiving intravenous injection of IL-1a (20 ng) or saline. *P,0.01 (n=4/group).
doi:10.1371/journal.pone.0026644.g007
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HSCs (also called vitamin A-storing cells, lipocytes, hepatic
pericytes, interstitial cells, fat-storing cells, and Ito cells) lodge in the
space between hepatocytes and sinusoidal endothelial cells. In the
normal liver, HSCs are assumed to have two major physiological
functions. First, HSCs store 80% of whole body’s retinoid in the
form of retinyl ester in the cytoplasm [17]. Second, HSCs produce
basement-membrane-like ECM scaffolds for mechanical support of
the sinuosids. Upon injury, HSCs organize tissue repair and wound
healing in multiple directions. For instance, when stimulated by
inflammatory cytokines and in sensing of surrounding ECM, HSCs
express a panel of MMPs, which can subsequently release cryptic
growth factors stored in ECM. On the other hand, also under injury
signals, HSCs mobilize stored retinyl esters and convert retinyl
esters into retinol, which can be subsequently oxidized to retinoic
acid to control and prevent over inflammation. Compelling
evidencehasdemonstrated criticalrolesofretinoidacid ininduction
of peripheral regulatory T cells from naive T cells, which may
subsequently quench inflammation [18–19]. A recent study showed
that although having weak antigen presentation function, HSCs can
prevent induced regulatory T cells from their conversion to Th17
cells [20]. Thus, presumably mobilization of retinoid in HSCs
induced by IL-1 may contribute to induction of regulatory T cells
for wound healing.
Vitamin A containing lipid droplets are regarded as a typical
marker of quiescent HSCs in normal liver. It is well believed that
mobilization or loss of retinoid storage in HSCs is one of key
features for HSCs in wound healing [21]. Study showed that
absence of lipid droplets in HSCs of LRAT
2/2 mice does not
enhance hepatic fibrosis, but decreases hepatic carcinogenesis
[22]. Like triglyceride, vitamin A storage in HSCs is mediated by
PPAR signaling [23]. However, it is still obscure that how vitamin
A storage is mobilized by HSCs in acute phase of liver damage. To
address this issue, we focused on LRAT, a well documented
enzyme controlling esterification of retinol for its storage in HSCs.
Figure 8. Down-regulation of LRAT in HSCs isolated from rat hepatic injury model. (A). Rats received a single subcutaneous injection of
mineral oil (control) or CCl4. HSCs were isolated 24 hours after treatment. HSCs were cultured for additional 24 hours after isolation. LRAT mRNA
levels in HSCs (A) and whole liver tissues (B) were measured by qRT-PCR. Results are expressed as folds of increase relative to control. *P,0.05 (n=3).
(C) Protein levels of LRAT, a-SMA, and IL-1b in whole liver tissue were analyzed by Western blot. GAPDH: loading control. (D) LRAT protein in HSCs
isolated from control and injured liver was detected by Western blot. (E) Double immunofluorescence staining for LRAT (red) and desmin (green) in
the liver of control and CCl4-injected rat. Original magnification 6200.
doi:10.1371/journal.pone.0026644.g008
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LRAT accompanying accumulated retinoid droplets. One future
direction is to address how 3D ECM up regulates LRAT
expression level.
Present study showed, for the first time to our knowledge, that
IL-1 can directly down-regulates LRAT expression, and mobilizes
retinoid in primary rat HSCs. We reached this conclusion through
a line of experimental approaches. First, we speculated that the
acute cytokines in the early phase of tissue injury may serve as
injury signals to mobilize retinyl ester. Through testing a panel of
acute inflammatory cytokines and growth factors we identified IL-
1 as a potent cytokine that can promptly mobilize and dispense
retinoid droplets by the quiescent rat HSCs. Second, we
demonstrated that IL-1 can promptly down regulate LRAT,
which provides a molecular basis to explain how mobilization of
retinoid occurs in HSCs and in acute liver injury. Third, to
elaborate such notion we additionally found that KCs and their
secreted mediators in the conditioned medium can elicit HSCs,
resulting in LRAT down-regulation, suggesting patho-physiolog-
ical cellular interaction in the liver wound healing. KCs are the
major innate immune cells in the liver. Different from other
macrophages, KCs in the liver are keen on immune tolerance
[24]. After injury or infection, KCs can be promptly activated to
secrete pro-inflammatory cytokines and other growth factors.
Importantly, we demonstrated that IL-1 as a major, if not the
exclusive signal from KCs to elicit HSCs for down regulation of
LRAT. Such notion is based on results from in vitro neutralization
by IL-1RA and in vivo depletion of KCs by liposomal clodronate
(Feng et al., unpublished data). Fourth, the role of IL-1 in injury-
induced mobilization of retinyl ester and down-regulation of
LRAT was demonstrated here by variety of animal models. Our
animal work started from establishing an inverse association
between upraising of IL-1 and down-regulation of LRAT as well
as mobilization of retinyl ester in the acute phase. Then, through
gain-of-function analysis by direct administration of IL-1, we
found IL-1 alone is sufficient to exert down-regulation of LRAT in
the liver, in a way bypassing injury and inflammation. In a
complementary approach through loss-of-function analysis, we
showed that IL-1R
2/2 mice are partially devoid of injury-induced
down-regulation of LRAT. Finally, in a rat model challenged by
different hepatic toxin we confirmed the relationship between IL-1
elevation and down-regulation of LRAT in the acute phase of liver
injury. Taken together, these results prompted us to reach the
conclusion that IL-1 may function as injury signal controlling
mobilization of retiny ester through down-regulation of LRAT in
liver injury. In addition to IL-1, other cytokines such as TNF-a,a t
a less extent, may also suppress LRAT expression in vivo. In fact,
the partial protection of LRAT down-regulation in IL-1R deficient
mice after injury also indicates contribution of other factors such as
TNF-a. Since both IL-1 and TNF-a can be generated either from
hepatic source or systemic way by other organs under inflamma-
tion, HSC derived retinol or retinoic acid may contribute to
systemic wound healing for other organs. In particular, retinoic
acid produced in acute phase of injury may participate in immune
regulation/suppression through induction of regulatory T cells for
termination of inflammation and wound closure.
Beside LRAT, there are several other critical factors controlling
retinoids metabolism in HSCs. CRBP-I deficient mice showed an
approximately 50% reduction of retinoid accumulation [25]. Such
phenomena probably reflect an impaired delivery of retinol as a
substrate for LRAT. Diacylglycerol acyltransferase-1 (DGAT-1)
was reported to be highly expressed in HSCs [26] and function as
an ARAT by using acetyl co-A as a carrier [27]. However, there
was no difference in hepatic retinyl ester levels between DGAT-1
null mice and matched WT mice. Additionally, the role of LRAT
as the major retinol esterification enzyme in liver was proved by
LRAT
2/2 mice [15]. Paradoxically, as Hellemans and coworkers
reported [23], we observed time-dependent up-regulation of
LRAT expression in culture activated HSCs, which may imply a
compensatory feedback to restore the lost retinyl ester. Since
HSCs mostly store retinoids transferrd from hepatocytes, HSCs
can hardly uptake retinol without hepatocytes in our culture
system. The up-regulation of LRAT expression does not
necessarily reflect the quiescence of HSCs. Vice versa, in LRAT
2/2
mice, which showed intense loss of hepatic retinoid storage,
neither myofibroblastic change of HSC nor liver fibrogenesis was
observed [7].
In Western blot for LRAT, we frequently observed doubled
bands of LRAT. The predicted size of LRAT protein is 25 kDa.
Although Moise and coworkers speculated that the lower band is
most likely proteolytic products [28], nobody confirmed their
speculation. When overexpressed in 293A cells, LRAT protein
also showed the doublets (Fig. 5A). Therefore, the double bands
are likely derived from coding region of LRAT cDNA, rather than
RNA splicing. We still do not know the significance of the doublet
and how they are generated. LRAT gene was constitutively
transcribed by HSCs in basal state of the normal liver. Our data
showed that ECM in 3D context can elevate LRAT expression at
basal state, which is in line with increased storage of retiny ester,
and coincides with quiescent phenotypes of HSCs in the normal
liver. Thus it is possible that ECM produced by HSCs in autocrine
manner may enforce the cells to express LRAT and accumulate
retinyl ester. This is particularly reasonable in terms of
microenvironment that determines gene expression through a
negative feedback loop. However, up-regulation of LRAT, as
observed by HSC activation in current study, is not sufficient to
promote retinol esterification. Other factors such as substrate
availability and carrier proteins are also required for storage of
retinyl esters. Although PPARb is reported to be an inducer of
LRAT expression in HSCs [23], regulators of LRAT expression
are largely unknown at present.
In present study, it is still unknown how IL-1 suppresses LRAT
expression at molecular level. Under IL-1 stimulation, both
mRNA and protein of LRAT decayed by an intimate pace.
These results suggest that IL-1 regulates LRAT expression mainly
at mRNA level. In contrast, protein degradation by IL-1 is an
unlikely mechanism to control LRAT expression, or may not
contribute to regulation of LRAT expression at substantial level.
The key evidence for this notion comes from the fact that
ectopically expressed LRAT was devoid of down-regulation by IL-
1, suggesting IL-1 does not control LRAT protein degradation.
Future work will address how IL-1 suppresses the transcription of
LRAT gene. IL-1 can drive four kinase pathways, including IKK,
p38 MAPK, JNK, and ERK. Two major transcription factors,
NF-kB and AP1, after activation, are recruited to the cis-elements
in the targeting genes. The response elements of IL-1 signaling are
not apparently found in the proximal region of LRAT, but are
evident in distal region of LRAT gene (data not shown). It is
openly possible that suppression of LRAT gene is initiated by IL-
1-regulated transcription factors that target the cis-elements, which
subsequently recruit suppressors/co-suppressors into the gene.
Alternatively, decreased mRNA of LRAT may be regulated at
mRNA stability. Such scenario is elaborated by the evidence that
LRAT mRNA contains 4000 bp 39-untranslated region (UTR),
which is conserved among different species.
Hepatic toxin induced liver damage, in a similar way to other
organs, is initiated by activation pattern recognition receptors
(PRR) including toll-like-receptors (TLRs), mannose receptors,
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matory cytokines such as IL-1 and TNF-a. For instance, a report
showed that acetaminophen induced liver injury is mediated by
activation of TLR-9 and inflammasome that release mature IL-1
through caspase-1 [29]. Our results suggested that KCs may
mediate retinoids storage reduction through secretion of IL-1
(Fig. 6). In addition to KCs, sinusoidal endothelial cells may also
provide IL-1 through diverse routes including TLR-9 [29,30].
Moreover, our preliminary work showed that HSCs in 3D ECM
can substantially generate IL-1 in an autocrine manner to amplify
the injury signal. Thus, it is possible that the signals triggering
mobilization of retinyl esters in HSCs and activation of HSCs may
come from diverse sinusoidal cells. Although our attention has
been paid to IL-1, TNF-a at a less extent can drive down LRAT
expression. Such differential responsiveness to these two cytokines
may be derived from the receptor abundance and intracellular
signal machinery in a particular cell type. According to our
preliminary data, we noticed that, in terms of MMP expression,
rat HSCs are more sensitive to IL-1 than TNF-a, whereas mouse
HSCs oppositely show higher sensitivity to IL-1 than TNF-a than
IL-1.
Materials and Methods
Primary hepatic stellate cells and Kupffer cells
HSCs and KCs were isolated from normal male Wistar rats
(Charles River, Charleston, CA) using collagenase/pronase
digestion and arabinogalactan gradient ultracentrifugation as
described previously and provided by the Non- Parenchymal
Liver Cell Core of the USC Research Center for Alcoholic Liver
and Pancreatic Diseases [31]. The resulting primary HSCs have
considerably high purity in 90%, as judged by auto-fluorescence of
retinol droplets, desmin and LRAT staining, and star-like
morphology. The purity of KCs, also around 90%, is determined
by FACS with anti-F4/80 staining. After recovery for 2–3 days
following isolation, HSCs were seeded on plastic or embedded in
3D ECM as previously described [13]. All cytokines and growth
factors were purchased from R&D systems (Minneapolis, MN).
Animal model of acute liver injury
B6.129S wild type (WT) mice, and IL-1 receptor deficient (IL-
1R
2/2) mice (B6.129S7-Il1r1tm1Imx) (Jackson Laboratory, Bar
Harbor, ME) received a single intraperitoneal injection of
thioacetamide (TAA; Sigma-Aldrich, St. Lois, MO) at the dosage
of 200 mg/g body weight or normal saline as control. Mice were
sacrificed at the time points indicated in figures. In one
experiment, WT mice were intravenously injected 20 ng of IL-
1a or normal saline. To test injury-induced regulation of LRAT in
rat model, male Wistar rats (Charles River) were given a single
dose of CCl4 (Sigma-Aldrich, 1.5 ml/kg body weight, by
subcutaneous injection) or mineral oil after priming with 0.5%
phenobarbital (Sigma) in drinking water for a week. After
24 hours, liver tissues were harvested for analyses, and HSCs
were subsequently isolated from the rat liver tissues [31].
Ectopic expression of LRAT by adenovirus in rat HSCs
We cloned rat LRAT cDNA by reverse transcription of RNA
extracts from primary rat HSCs, using following set of primers, 59-
CGGGATCCGCGAGAAACTCTGGTCTTTAAAGGATG-39
(BamHI recognition site is underlined), and 59-GGAATTCG-
GAAGCTAGCCAGACATCATCC-39 (EcoRI recognition site is
underlined). After double-digestion with BamHI and EcoRI, the
PCR product was cloned into pAd/CMV/VS-DEST adenoviral
vector (Ad.LRAT; Invitrogen, Carlsbad, CA), followed by
sequencing confirmation. GFP expressing adenoviral vector was
used as control (Ad.GFP). Adenoviral vectors were amplified using
293A cells and purified with cesium chloride gradient centrifuga-
tion. On day 2 after initial isolation, HSCs were transduced by
Ad.GFP or Ad.LRAT at MOI of 100. On day 5, the cultures were
stimulated with or without IL-1a at 10 ng/ml for additional 3
days. For lipid staining, cells were treated with 5 mM retinol
(Sigma-Aldrich) and 100 mM palmitate (Sigma-Aldrich) for
24 hours and incubated with 0.2% Oil red O (Sigma-Aldrich)
for 5 hours.
Retinyl palmitate measurement
The procedure for lipid extraction and retinyl palmitate
measurement were adopted from others with some modifications
[32]. Briefly, liver samples (100 mg) or HSCs (1–2610
6 cells) were
extracted in chloroform with 0.1% formic acid in glass tubes
protected from light. All-trans-retinoic acid was added in
extractions as internal standard to trace the systemic variation.
After drying up solvent under N2, samples were reconstituted in
chloroform with 0.1% formic acid, followed by HPLC (Agilent
1100) analysis. Retinyl palmitate and internal standards were
detected by Applied Biosystems API 3000 LC/MS/MS triple
quadrupole mass spectrometer with APCI source.
Quantitative RT-PCR (qRT-PCR)
Total RNAs were extracted from rat HSCs or livers using
TRIzol reagent (Invitrogen). Two micrograms of RNAs were
transcribed using M-MLV reverse transcriptase (Invitrogen) and
amplified with qPCR Mastermix Plus for SYBR Green I
(Eurogentec, San Diego, CA) as previously described [33]. The
primers were listed in Table.
DNA Microarray Analysis
Rat HSCs were cultured on plastic or embedded in Col-I and
Matrigel respectively [13]. After 24 hour recovery in DMEM with
10% fetal bovine serum (FBS), the cells were challenged by IL-1a
at 10 ng/ml in 1% FBS for 18 hours. Total RNA was extracted
with Trizol (Invitrogen) and purified by RNeasy Clean up column
(QIAGEN, Valencia, CA). RNA was amplified, labeled, and
Table 1. Primer sequences used for qRT-PCR.
Mouse and rat LRAT:
Forward 59-ACA AGG AAC GCA CTC AGA AGG T-39
Reverse 59-ATG CTG GCC ACC TTG CAA AT-39
Rat CRBP-I:
Forward 59-AGG GTG ATG AAC TTC ACC TGG A-39
Reverse 59-TTC GGG CTG CTC AGT GTA CTT T -39
Mouse IL-1a:
Forward 59-CAC AAC TGT TCG TGA GCG CT-39
Reverse 59-TTG GTG TTT CTG GCA ACT CCT-39
Mouse IL-1b:
Forward 59-ACT CCT TAG TCC TCG GCC A-39
Reverse 59-TGG TTT CTT GTG ACC CTG AGC-39
Mouse and rat GAPDH:
Forward 59-GCA CAG TCA AGG CCG AGA AT-39
Reverse 59-GCC TTC TCC ATG GTG GTG AA -39
doi:10.1371/journal.pone.0026644.t001
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according to standard Affymetrix protocols.
Western blot analysis
The procedure for protein preparation from HSCs was
previously described [13]. For liver tissue, 100 mg of sample was
homogenized in 1 ml of NT buffer (100 mM NaCl, 50 mM Tris-
HCl, pH 7.5) by Dounce homogenizer. The homogenate was
mixed and boiled with 26 sample buffer for SDS-PAGE with
reducing agent. Anti-LRAT mouse monoclonal antibody (at 1:100),
as a gift kindly provided by Dr. Krzysztof Palczewski [19], anti-IL-
1b antibody (1:1000) (R&D systems), anti-a-smooth muscle actin
antibody (1:1000) (a-SMA; Sigma) and anti-glyceraldehydes-3-
phosphate dehydrogenase (GAPDH) antibody (1:1000) (Chemicon,
Temecula, CA), and HRP-conjugated secondary antibody (Santa
Cruz Biotech, Santa Cruz, CA) were used for Western blot analysis.
Blots were visualized by the enhanced chemiluminescence detection
system (Thermo, Rockford, IL).
Immunofluorescence staining
HSCs were fixed by cold methanol followed by permeabiliza-
tion with 0.1% Triton X100 in PBS and blocked with 10% bovine
serum albumin (BSA). Then the cells were incubated with anti-
LRAT antibody (1:100) overnight. To detect primary antibody,
the cells were incubated with Cy3 conjugated anti-mouse IgG
(1:500) (Sigma) for 1 hour. Nuclei were stained with 49,6-diamino-
2-phenylindole (DAPI, 1 mg/ml) for 10 min. Cryosections of rat
liver were fixed with 4% paraformaldehyde and blocked with 10%
BSA in PBS, followed by incubation with anti-LRAT antibody
(1:100) or anti-desmin antibody (1:200) (Abcam, Cambridge, MA)
and fluorophore conjugated secondary antibodies.
Kupffer cell conditioned medium and treatment of HSCs
KCs seeded on 10-cm dishes were cultured in DMEM with 1%
FBS for 3 days to prepare the conditioned medium (KC-CM). In
some experiments KCs were additionally activated by lipopoly-
saccharide (LPS, 5 mg/ml). Then, primary rat HSCs were exposed
to KC-CM in presence with or without IL-1 receptor antagonist
(IL-1RA) (R&D systems, 1 mg/ml) for 18 hours.
Gelatinolytic zymography
Liver tissues (100 mg) from the mice subjected to IL-1 challenge
or control treatment were extracted in 1 ml of NT buffer (100 mM
NaCl, 50 mM Tris-HCl, pH 7.5). The gelatinases in tissue
extracts were enriched by gelatin-conjugated Sepharose-4B,
followed by zymography [34].
Statistical analysis
All numerical data were expressed as mean 6 S.D. The
significance of the differences between two groups was assessed
using Student’s t test. A P value of less than 0.05 was considered
statistically significant.
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